Kloiber, Stacey External Entity

Publications

Sort by

Selected publications

  • Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial.  Annals of the rheumatic diseases2011 Academic Article GET IT
    Times cited: 90